Skip to main content

Recombinant Human Integrin alpha E beta 7 Protein, CF

R&D Systems, part of Bio-Techne | Catalog # 5850-A3

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
5850-A3-050

Key Product Details

Source

CHO

Conjugate

Unconjugated

Applications

Binding Activity

Product Specifications

Source

Chinese Hamster Ovary cell line, CHO-derived human Integrin alpha E beta 7 protein
Human Integrin alphaE
(Phe19-Ser1124 (Ile477Val & Arg482Gln))
Accession # P38570
GGGSGGGS Acidic Tail 6-His tag
Human Integrin beta7
(Glu20-His723)
Accession # P26010
His-Pro GGGSGGGS Basic Tail
N-terminus C-terminus

Purity

>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Phe19 ( alphaE) & Glu20 ( beta7)

Predicted Molecular Mass

130.7 kDa ( alphaE) & 84.7 kDa ( beta7)

SDS-PAGE

150-170 kDa & 120-130 kDa, reducing conditions

Activity

Measured by its binding ability in a functional ELISA.
When rhE-Cadherin is coated at 2 μg/mL, rhIntegrin alphaE beta7 binds with an apparent Kd <5 nM.

Formulation, Preparation and Storage

5850-A3
Formulation Lyophilized from a 0.2 μm filtered solution in PBS.
Reconstitution
Reconstitute at 100 μg/mL in PBS.

Reconstitution Buffer Available:
Size / Price
Qty
Loading...
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: Integrin alpha E beta 7

Integrin alphaE beta7, also called HML-1 (human mucosal lymphocyte antigen), is the only known integrin family adhesion receptor containing the alphaE (epithelial-associated) subunit, and shares the beta7 subunit with alpha4 beta7 (1-3). alphaE beta7 is the non‑covalent multimer of alphaE (designated CD103), present as 150 kDa and 25 kDa heavy and light chains, and 130 kDa beta7 type I transmembrane glycoprotein subunits (2, 3). The alphaE extracellular N-terminal beta-propeller structure contains X (which contains the cleavage site) and I domains, and is followed by domains called thigh, calf-1 and calf-2 (1, 2). The beta7 ECD contains a vWFA domain, which interacts with the alphaE beta-propeller to form a binding domain. The MIDAS motif (metal ion‑dependent adhesion site) is critical for binding of alphaE beta7 to its ligand (4). Each subunit has a transmembrane sequence and a short cytoplasmic tail. The 1105 aa human alphaE extracellular domain shares 70-79% aa sequence identity with mouse, rat, equine, bovine, canine and feline alphaE, while the 705 aa human beta7 ECD shares 87%, 87%, 91% and 88% aa identity with mouse, rat, equine and bovine beta7, respectively. alphaE beta7 is mainly restricted to mucosal tissues, where it engages the epithelial adhesion molecule E-cadherin (4-6). It was first identified as a marker of intestinal intra-epithelial lymphocytes (2, 5, 6). It has since been recognized that a variety of leukocytes, such as cytotoxic CD8+ T cells, some dendritic cells, and effector/memory-like regulatory T cells, acquire alphaE beta7 in the days following their migration to epithelial tissues such as the intestines, lungs, and epithelial layers of tonsils (6-13). In these tissues alphaE beta7 facilitates immune surveillance, including destruction of infected or transformed epithelial cells and induction of T cell adaptive responses (7-13). Pathologically, alphaE beta7 may be involved in allograft rejection of transplanted pancreatic islets and other tissues (14).

References

  1. Luo, B-H. et al. (2007) Annu. Rev. Immunol. 25:619.
  2. Shaw, S.K. et al. (1994) J. Biol. Chem. 269:6016.
  3. Erle, D.J. et al. (1991) J. Biol. Chem. 266:11009.
  4. Higgins, J.M.G. et al. (2000) J. Biol. Chem. 275:25652.
  5. Cepek, K.L. et al. (1994) Nature 372:190.
  6. Wagner, N. et al. (1996) Nature 382:366.
  7. Le Floc’h, A. et al. (2007) J. Exp. Med. 204:559.
  8. Smyth, L.J.C. et al. (2007) Clin. Exp. Immunol. 149:162.
  9. Woodberry, T. et al. (2005) J. Immunol. 175:4355.
  10. Jaensson, E. et al. (2008) J. Exp. Med. 205:2139.
  11. del Rio, M.-L. et al. (2008) J. Immunol. 181:6178.
  12. Sung, S.J. et al. (2006) J. Immunol. 176:2161.
  13. Siewert, C. et al. (2008) J. Immunol. 180:146.
  14. Feng, Y. et al. (2002) J. Exp. Med. 196:877.

Additional Integrin alpha E beta 7 Products

Product Documents for Recombinant Human Integrin alpha E beta 7 Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Recombinant Human Integrin alpha E beta 7 Protein, CF

For research use only

Loading...
Loading...
Loading...
Loading...